Clinical Trial Update: Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating LY3848575 vs placebo in participants with painful distal sensory polyneuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Sensory Polyneuropathy
• Neuropathic Pain

Drugs mentioned

• LY3848575

Snippet

Sponsor: Eli Lilly and Company | Conditions: Neuropathic Pain, Distal Sensory Polyneuropathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING